Quick Answer
BioCorRx Inc. reported Research And Development Expense of $1.77 million for the year ending 2025.
- BioCorRx Inc. showed an increase of +19.3% in Research And Development Expense from 2024 to 2025.
- This data is from BioCorRx Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 9 years of available data (2017 to 2025), BioCorRx Inc.'s Research And Development Expense has grown by 292.5%.
- Historical annual values: Fiscal year 2025: $1.77 million | Fiscal year 2024: $1.48 million | Fiscal year 2023: $891.1 thousand | Fiscal year 2022: $1.46 million | Fiscal year 2021: $1.61 million | Fiscal year 2020: $4.27 million | Fiscal year 2019: $1.13 million | Fiscal year 2018: $151.8 thousand | Fiscal year 2017: $450.7 thousand.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: